NASDAQ : SNY
Sanofi — Key statistics
Healthcare · Drug Manufacturers - General · France
Last price 43.13 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 101.86B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 106.67B |
| Enterprise Value | 122.57B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | May 4, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 1.20B |
| Shares Change (YoY) | -2.18% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 43.15% |
| Float | 1.08B |
Ratios
| Measure | Value |
|---|
| PE Ratio | 22.99 |
| Forward PE | 9.04 |
| PS Ratio | 1.84 |
| Forward PS | 1.89 |
| PB Ratio | 1.28 |
| P/TBV Ratio | 17.88 |
| P/FCF Ratio | 9.59 |
| P/OCF Ratio | 7.99 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 25.83 |
| EV / Sales | 2.12 |
| EV / EBITDA | 7.46 |
| EV / EBIT | 9.77 |
| EV / FCF | 11.02 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.12 |
| Quick Ratio | 0.21 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.35 |
| Debt / FCF | 2.03 |
| Interest Coverage | 17.51 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 5.71% |
| Return on Assets (ROA) | 5.31% |
| Return on Invested Capital (ROIC) | 9.02% |
| Return on Capital Employed (ROCE) | 10.99% |
| Weighted Average Cost of Capital (WACC) | 5.18% |
| Revenue Per Employee | $773,517 |
| Profits Per Employee | $63,390 |
| Employee Count | 74,846 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 0.54 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.95B |
| Effective Tax Rate | 29.05% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -12.51% |
| 50-Day Moving Average | 42.21 |
| 200-Day Moving Average | 44.33 |
| Relative Strength Index (RSI) | 68.38 |
| Average Volume (20 Days) | 3,992,057 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 11.61M |
| Short Previous Month | 10.61M |
| Short % of Shares Out | 0.97% |
| Short % of Float | 1.08% |
| Short Ratio (days to cover) | 3.47 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 57.89B |
| Gross Profit | 42.66B |
| Operating Income | 12.55B |
| Pretax Income | 6.71B |
| Net Income | 4.74B |
| EBITDA | 16.43B |
| EBIT | 12.55B |
| Earnings Per Share (EPS) | $1.93 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 6.77B |
| Total Debt | 22.54B |
| Net Cash | -15.76B |
| Net Cash Per Share | -$13.13 |
| Equity (Book Value) | 83.17B |
| Book Value Per Share | 68.97 |
| Working Capital | 3.91B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 13.34B |
| Capital Expenditures | -2.22B |
| Depreciation & Amortization | 3.81B |
| Net Borrowing | 1.68B |
| Free Cash Flow | 11.13B |
| FCF Per Share | $9.27 |
Margins
| Measure | Value |
|---|
| Gross Margin | 73.68% |
| Operating Margin | 21.67% |
| Pretax Margin | 11.59% |
| Profit Margin | 8.20% |
| EBITDA Margin | 28.37% |
| EBIT Margin | 21.67% |
| FCF Margin | 19.56% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $2.42 |
| Dividend Yield | 5.46% |
| Dividend Growth (YoY) | 10.19% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 133.01% |
| FCF Payout Ratio | 25.90% |
| Buyback Yield | 2.18% |
| Shareholder Yield | 7.63% |
| Earnings Yield | 4.35% |
| FCF Yield | 10.43% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $53.61 |
| Price Target Difference | 20.91% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 4.70% |
| EPS Growth Forecast (3Y) | 7.83% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |